Fennec Pharmaceuticals Inc. (NASDAQ: FENC) Stock Information | RedChip

Fennec Pharmaceuticals Inc. (NASDAQ: FENC) Listen to this Section


$5.58
N/A ( 0% ) 41.9K

Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.

Market Data


Open


$5.58

Previous close


$5.58

Volume


41.9K

Market cap


$152.15M

Day range


$5.55 - $5.69

52 week range


$5.26 - $11.92

Insider Ownership Transactions

Total Amount Purchased: -362,211.00 | $ -2,021,137.38

Date Type Amount Purchased Purchaser
2024-08-01 Sale -1042.00 Andrade Robert
2024-08-01 Sale -2431.00 Raykov Rosty
2024-07-08 Sale -1792.00 RALLIS CHRIS A
2024-07-02 Sale -2431.00 Raykov Rosty
2024-07-02 Sale -1042.00 Andrade Robert
2024-06-03 Sale -1042.00 Andrade Robert
2024-06-03 Sale -2431.00 Raykov Rosty
2024-05-21 Sale -200000.00 Raykov Rosty
2024-05-21 Sale -50000.00 Haigh Adrian
2024-05-21 Sale -100000.00 Andrade Robert

SEC Fillings


Form Type Description Pages Date
10-q Quarterly Reports 62 Aug 13, 2024
8-k 8K-related 17 Aug 07, 2024
4 Insider transactions 1 Aug 01, 2024
4 Insider transactions 1 Aug 01, 2024
4 Insider transactions 1 Jul 08, 2024
4 Insider transactions 1 Jul 02, 2024
8-k 8K-related 16 Jul 02, 2024
4 Insider transactions 1 Jul 02, 2024
8-k 8K-related 13 Jun 25, 2024
4 Insider transactions 1 Jun 03, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.